Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ERN1 | O75460 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PLAU | P00749 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7086751 | 0.79 | PTPN11 (0.50) | GPR35TDP1KMT2AMEN1MAPK1 | |
| SCHEMBL7136437 | 0.77 | TDP1 (0.46) | GPR35TDP1KMT2AMEN1MAPK1 | |
| SCHEMBL33832 | 0.77 | TDP1 (0.46) | GPR35TDP1KMT2AMEN1MAPK1 | |
| SCHEMBL1036583 | 0.75 | TDP1 (0.45) | GPR35TDP1KMT2AMEN1GAA | |
| SCHEMBL1179475 | 0.75 | TDP1 (0.45) | GPR35TDP1KMT2AMEN1MAPK1 | |
| SCHEMBL7907932 | 0.75 | TDP1 (0.45) | GPR35TDP1KMT2AMEN1MAPK1 | |
| SCHEMBL2075134 | 0.75 | TDP1 (0.45) | GPR35TDP1KMT2AMEN1HSD17B10 | |
| SCHEMBL8374 | 0.75 | TDP1 (0.54) | GPR35TDP1KMT2AMEN1MAPK1 | |
| SCHEMBL9336847 | 0.75 | GPR35 (0.54) | GPR35TDP1KMT2AMEN1MAPK1 | |
| SCHEMBL2193448 | 0.75 | TDP1 (0.45) | GPR35TDP1KMT2AMEN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2079757-B1 | PROCESS FOR SELECTIVELY LOCALIZING ACTIVE INGREDIENTS ON AND IN MITOCHONDRIA AND CORRESPONDING ACTIVE INGREDIENTS | UGICHEM GES FÜR ORGANISCHE CHEMIE MBH (AT) | 2014-12-17 | — | — | EP | claimed |
| US-20130101517-A1 | DEVELOPMENT OF PHOTOSTABLE NEAR-IR CYANINE DYES FOR IN VIVO IMAGING | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-04-25 | — | — | US | claimed |
| EP-2550338-A1 | DEVELOPMENT OF PHOTOSTABLE NEAR-IR CYANINE DYES FOR IN VIVO IMAGING | National University of Singapore (SG) | 2013-01-30 | — | — | EP | claimed |
| WO-2011119114-A1 | DEVELOPMENT OF PHOTOSTABLE NEAR-IR CYANINE DYES FOR IN VIVO IMAGING | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2011-09-29 | — | — | WO | claimed |
| US-20100261765-A1 | MINERALOCORTICOID RECEPTOR MODULATORS | MERCK SHARP & DOHME CORP. | 2010-10-14 | — | — | US | claimed |
| EP-2229167-A1 | MINERALOCORTICOID RECEPTOR MODULATORS | Merck Sharp & Dohme Corp. (US) | 2010-09-22 | — | — | EP | claimed |
| WO-2009078934-A1 | MINERALOCORTICOID RECEPTOR MODULATORS | MERCK & CO., INC. (US) | 2009-06-25 | — | — | WO | claimed |
| EP-0886640-B1 | SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES | GLYCOMIMETICS INC (US) | 2007-03-21 | — | — | EP | claimed |
| US-20060084176-A1 | Detection of uronium salts | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-04-20 | — | — | US | claimed |
| US-20040102650-A1 | Solid phase synthesis of arylretinamides | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-05-27 | — | — | US | claimed |
| US-20030105164-A1 | Solid phase synthesis of arylretinamides | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2003-06-05 | — | — | US | claimed |
| WO-2003003987-A2 | SOLID PHASE SYNTHESIS OF ARYLRETINAMIDES | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2003-01-16 | — | — | WO | claimed |
| US-6169077-B1 | A SIALYLATED AND FUCOSYLATED CARBOHYDRATE; USE AS ANTIADHESION THERAPEUTICS TREATING INFLAMMATIONS, THEY CAN PREVENT THE SELECTIN RECEPTORS FROM BINDING TO ACTIVATED ENDOTHELIAL CELLS ON THE SURFACE OF LEUCOCYTES | GLYCOTECH CORP. | 2001-01-02 | — | — | US | claimed |
| EP-0886640-A1 | SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES | GlycoTech Corp. (US) | 1998-12-30 | — | — | EP | claimed |
| WO-1997028173-A1 | SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES | NOVARTIS AG (CH) | 1997-08-07 | — | — | WO | claimed |
| EP-0370492-B1 | INDOLE-ALDEHYDE HAIR DYES | Bristol-Myers Squibb Company (US) | 1993-01-27 | — | — | EP | claimed |
| US-5108502-A | Azo dyes; water solubility; utility in inks for ink-jet printing | HEWLETT-PACKARD COMPANY (US) | 1992-04-28 | — | — | US | claimed |
| US-4932977-A | Indole-aldehyde hair dyes | CLAIROL INCORPORATED (US) | 1990-06-12 | — | — | US | claimed |
| EP-0370492-A1 | Indole-aldehyde hair dyes | Bristol-Myers Squibb Company (US) | 1990-05-30 | — | — | EP | claimed |
| WO-2024108068-A2 | METHODS OF EVALUATING VIRUS-PRODUCING CELLS | BRUKER CELLULAR ANALYSIS, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024077101-A2 | COMPOSITIONS FOR MICROFLUDIC WORKFLOWS AND METHODS OF USE THEREOF | BRUKER CELLULAR ANALYSIS, INC. (US) | 2024-04-11 | — | — | WO | disclosed |
| WO-2024076923-A1 | MICRO-OBJECT DISPLACEMENT WITHIN A MICROFLUIDIC ENVIRONMENT | BRUKER CELLULAR ANALYSIS, INC. (US) | 2024-04-11 | — | — | WO | disclosed |
| US-20230375447-A1 | METHOD FOR ASSAYING A MICRO-OBJECT WITHIN A MICROFLUIDIC DEVICE | BRUKER SPATIAL BIOLOGY, INC. | 2023-11-23 | — | — | US | disclosed |
| WO-2023147334-A9 | METHODS OF ASSAYING MICRO-OBJECTS IN A MICROFLUIDIC DEVICE | Berkeley Lights, Inc. (US) | 2023-08-31 | — | — | WO | disclosed |
| WO-2023164623-A2 | APPARATUSES, METHODS, AND KITS FOR MICROFLUIDIC ASSAYS | Berkeley Lights, Inc. (US) | 2023-08-31 | — | — | WO | disclosed |
| WO-2023147334-A1 | METHODS OF ASSAYING MICRO-OBJECTS IN A MICROFLUIDIC DEVICE | Berkeley Lights, Inc. (US) | 2023-08-03 | — | — | WO | disclosed |
| US-20230182136-A1 | IN SITU-GENERATED MICROFLUIDIC ISOLATION STRUCTURES, KITS AND METHODS OF USE THEREOF | Berkeley Lights, Inc. (US) | 2023-06-15 | — | — | US | disclosed |
| US-11666913-B2 | In situ-generated microfluidic isolation structures, kits and methods of use thereof | BERKELEY LIGHTS, INC (US) | 2023-06-06 | — | — | US | disclosed |
| CN-111225900-A | 3, 4-disubstituted 3-cyclobutene-1, 2-diones and their use | 阿勒根公司 | 2020-06-02 | — | — | CN | disclosed |
| EP-3380238-A1 | IN SITU-GENERATED MICROFLUIDIC ISOLATION STRUCTURES, KITS AND METHODS OF USE THEREOF | Berkeley Lights, Inc. (US) | 2018-10-03 | — | — | EP | disclosed |
| US-20170165667-A1 | IN SITU-GENERATED MICROFLUIDIC ISOLATION STRUCTURES, KITS AND METHODS OF USE THEREOF | BRUKER CELLULAR ANALYSIS, INC. | 2017-06-15 | — | — | US | disclosed |
| US-20170079954-A1 | PHARMACEUTICALLY ACCEPTABLE SALTS OF 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | AXIKIN PHARMACEUTICALS, INC. | 2017-03-23 | — | — | US | disclosed |
| US-9540351-B2 | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors | AXIKIN PHARMACEUTICALS, INC. (US) | 2017-01-10 | — | — | US | disclosed |
| EP-3046918-A1 | PHARMACEUTICALLY ACCEPTABLE SALTS OF 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | Axikin Pharmaceuticals, Inc. (US) | 2016-07-27 | — | — | EP | disclosed |
| US-9382237-B2 | 3,5-diaminopyrazole kinase inhibitors | AXIKIN PHARMACEUTICALS, INC. (US) | 2016-07-05 | — | — | US | disclosed |
| US-9365556-B2 | 3,5-diaminopyrazole kinase inhibitors | AXIKIN PHARMACEUTICALS, INC. (US) | 2016-06-14 | — | — | US | disclosed |
| US-9346792-B2 | 3,5-diaminopyrazole kinase inhibitors | AXIKIN PHARMACEUTICALS, INC. (US) | 2016-05-24 | — | — | US | disclosed |
| CN-105198872-A | Chromenone analogs as sirtuin modulators | SIRTRIS PHARMACEUTICALS INC | 2015-12-30 | — | — | CN | disclosed |
| US-9201014-B2 | Development of photostable near-IR cyanine dyes for in vivo imaging | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2015-12-01 | — | — | US | disclosed |
| CN-102227417-B | Chromenone analogs as sirtuin modulators | SIRTRIS PHARMACEUTICALS, INC. (US) | 2015-09-16 | — | — | CN | disclosed |
| US-20150105389-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | AXIKIN PHARMACEUTICALS, INC. | 2015-04-16 | — | — | US | disclosed |
| EP-2852586-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | Axikin Pharmaceuticals, Inc. (US) | 2015-04-01 | — | — | EP | disclosed |
| WO-2015042111-A1 | PHARMACEUTICALLY ACCEPTABLE SALTS OF 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | AXIKIN PHARMACEUTICALS, INC. (US) | 2015-03-26 | — | — | WO | disclosed |
| US-20150080398-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | AXIKIN PHARMACEUTICALS, INC. | 2015-03-19 | — | — | US | disclosed |
| US-20150080397-A1 | PHARMACEUTICALLY ACCEPTABLE SALTS OF 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | AXIKIN PHARMACEUTICALS, INC. | 2015-03-19 | — | — | US | disclosed |
| EP-2834232-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | Axikin Pharmaceuticals, Inc. (US) | 2015-02-11 | — | — | EP | disclosed |
| CN-104334545-A | 3,5-diaminopyrazole kinase inhibitors | AXIKIN PHARMACEUTICALS INC | 2015-02-04 | — | — | CN | disclosed |
| CN-104302640-A | 3,5-diaminopyrazole kinase inhibitors | AXIKIN PHARMACEUTICALS INC | 2015-01-21 | — | — | CN | disclosed |
| US-8916555-B2 | 3,5-diaminopyrazole kinase inhibitors | AXIKIN PHARMACEUTICALS, INC. (US) | 2014-12-23 | — | — | US | disclosed |
| US-20130303492-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | AXIKIN PHARMACEUTICALS, INC. | 2013-11-14 | — | — | US | disclosed |
| US-20130274227-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | AXIKIN PHARMACEUTICALS, INC. (US) | 2013-10-17 | — | — | US | disclosed |
| WO-2013138617-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | AXIKIN PHARMACEUTICALS, INC. (US) | 2013-09-19 | — | — | WO | disclosed |
| WO-2013138613-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | AXIKIN PHARMACEUTICALS, INC. (US) | 2013-09-19 | — | — | WO | disclosed |
| EP-2638047-A1 | SUBSTITUTED 4-BETA-ACRYLAMIDOPODOPHYLLOTOXIN CONGENERS AS ANTITUMOUR ANTIBIOTICS AND THE PROCESS FOR PREPARATION THEREOF | Council of Scientific and Industrial Research (IN) | 2013-09-18 | — | — | EP | disclosed |
| US-20130189727-A1 | Methods And Compositions For Cellular Imaging And Cancer Cell Detection Using Light Harvesting Conjugated Polymer-Biomolecular Conjugates | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2013-07-25 | — | — | US | disclosed |
| US-20130109029-A1 | Methods And Compositions For Cellular Imaging And Cancer Cell Detection Using Light Harvesting Conjugated Polymer-Biomolecular Conjugates | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2013-05-02 | — | — | US | disclosed |
| US-20130101517-A1 | DEVELOPMENT OF PHOTOSTABLE NEAR-IR CYANINE DYES FOR IN VIVO IMAGING | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-04-25 | — | — | US | disclosed |
| EP-2550338-A1 | DEVELOPMENT OF PHOTOSTABLE NEAR-IR CYANINE DYES FOR IN VIVO IMAGING | National University of Singapore (SG) | 2013-01-30 | — | — | EP | disclosed |
| WO-2012063250-A1 | SUBSTITUTED 4-BETA-ACRYLAMIDOPODOPHYLLOTOXIN CONGENERS AS ANTITUMOUR ANTIBIOTICS AND THE PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2012-05-18 | — | — | WO | disclosed |
| WO-2012002911-A1 | METHODS AND COMPOSITIONS FOR CELLULAR IMAGING AND CANCER CELL DETECTION USING LIGHT HARVESTING CONJUGATED POLYMER- BIOMOLECULAR CONJUGATES | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2012-01-05 | — | — | WO | disclosed |
| WO-2011119114-A1 | DEVELOPMENT OF PHOTOSTABLE NEAR-IR CYANINE DYES FOR IN VIVO IMAGING | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2011-09-29 | — | — | WO | disclosed |
| WO-2010146351-A1 | INDOLYLMETHYL-MORPHOLINE DERIVATIVES AS KINASE INHIBITORS | UCB PHARMA S.A. (BE) | 2010-12-23 | — | — | WO | disclosed |
| US-20100261765-A1 | MINERALOCORTICOID RECEPTOR MODULATORS | MERCK SHARP & DOHME CORP. | 2010-10-14 | — | — | US | disclosed |
| EP-2229167-A1 | MINERALOCORTICOID RECEPTOR MODULATORS | Merck Sharp & Dohme Corp. (US) | 2010-09-22 | — | — | EP | disclosed |
| CN-101547934-A | Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients | UGICHEM GES FUER ORGANISCHE CH (AT) | 2009-09-30 | — | — | CN | disclosed |
| EP-2079757-A2 | PROCESS FOR SELECTIVELY LOCALIZING ACTIVE INGREDIENTS ON AND IN MITOCHONDRIA AND CORRESPONDING ACTIVE INGREDIENTS | Ugichem Gesellschaft Für Organische Chemie MbH (AT) | 2009-07-22 | — | — | EP | disclosed |
| WO-2009078934-A1 | MINERALOCORTICOID RECEPTOR MODULATORS | MERCK & CO., INC. (US) | 2009-06-25 | — | — | WO | disclosed |
| US-7550510-B2 | Solid phase synthesis of arylretinamides | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-06-23 | — | — | US | disclosed |
| CN-101454287-A | Substituted cyanopyridines as protein kinase inhibitors | WYETH CORP (US) | 2009-06-10 | — | — | CN | disclosed |
| WO-2008049583-A3 | PROCESS FOR SELECTIVELY LOCALIZING ACTIVE INGREDIENTS ON AND IN MITOCHONDRIA AND CORRESPONDING ACTIVE INGREDIENTS | UGICHEM GES FUER ORGANISCHE CH (AT) | 2009-04-16 | — | — | WO | disclosed |
| WO-2008049583-A2 | PROCESS FOR SELECTIVELY LOCALIZING ACTIVE INGREDIENTS ON AND IN MITOCHONDRIA AND CORRESPONDING ACTIVE INGREDIENTS | Ugichem Gesellschaft für Organische Chemie mbH (AT) | 2008-05-02 | — | — | WO | disclosed |
| US-7335411-B2 | Method of producing a tire composition having improved silica reinforcement | BRIDGESTONE CORPORATION (JP) | 2008-02-26 | — | — | US | disclosed |
| US-20070254917-A1 | INTRACELLULAR RECEPTOR MODULATOR COMPOUNDS AND METHODS | LIGAND PHARMACEUTICALS INC. | 2007-11-01 | — | — | US | disclosed |
| EP-0886640-B1 | SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES | GLYCOMIMETICS INC (US) | 2007-03-21 | — | — | EP | disclosed |
| US-20060089446-A1 | Method of producing a tire composition having improved silica reinforcement | BRIDGESTONE CORPORATION | 2006-04-27 | — | — | US | disclosed |
| US-20060084176-A1 | Detection of uronium salts | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-04-20 | — | — | US | disclosed |
| US-20040102650-A1 | Solid phase synthesis of arylretinamides | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-05-27 | — | — | US | disclosed |
| CN-1146541-C | Beta-alanine derivatives | Ĭ��ר���ɷ�����˾ | 2004-04-21 | — | — | CN | disclosed |
| US-6696606-B2 | REACTING HEXACHLOROACETONE WITH TRIPHENYLPHOSPHINE; CHLORINATION OF RETINOIC ACID; THEN AROMATIC AMINE; ANTICANCER AGENTS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION | 2004-02-24 | — | — | US | disclosed |
| US-6576637-B1 | Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations, | MERCK PATENT GMBH (DE) | 2003-06-10 | — | — | US | disclosed |
| US-20030105164-A1 | Solid phase synthesis of arylretinamides | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2003-06-05 | — | — | US | disclosed |
| WO-2003003987-A2 | SOLID PHASE SYNTHESIS OF ARYLRETINAMIDES | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2003-01-16 | — | — | WO | disclosed |
| CN-1340046-A | Beta-alanine derivatives | MERCK PATENT GMBH (DE) | 2002-03-13 | — | — | CN | disclosed |
| EP-1153014-A2 | BETA-ALANINE DERIVATIVES | MERCK PATENT GmbH (DE) | 2001-11-14 | — | — | EP | disclosed |
| US-6169077-B1 | A SIALYLATED AND FUCOSYLATED CARBOHYDRATE; USE AS ANTIADHESION THERAPEUTICS TREATING INFLAMMATIONS, THEY CAN PREVENT THE SELECTIN RECEPTORS FROM BINDING TO ACTIVATED ENDOTHELIAL CELLS ON THE SURFACE OF LEUCOCYTES | GLYCOTECH CORP. | 2001-01-02 | — | — | US | disclosed |
| WO-2000048996-A2 | β-ALANINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2000-08-24 | — | — | WO | disclosed |
| EP-0886640-A1 | SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES | GlycoTech Corp. (US) | 1998-12-30 | — | — | EP | disclosed |
| WO-1997028173-A1 | SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES | NOVARTIS AG (CH) | 1997-08-07 | — | — | WO | disclosed |
| US-5399589-A | Oxalyl hydrazide-hydroxamic acid derivatives, their preparation and their use as fungicides | BASF AKTIENGESELLSCHAFT (DE) | 1995-03-21 | — | — | US | disclosed |
| EP-0602561-A1 | Oxalylhydrazide-hydroxamic acid derivatives, process for their preparation and their use as fungicides | BASF Aktiengesellschaft (DE) | 1994-06-22 | — | — | EP | disclosed |
| US-5283325-A | Anionic dyes for polyamides, oxide layers on aluminum and its alloys | SANDOZ LTD. (CH) | 1994-02-01 | — | — | US | disclosed |
| US-5191073-A | Indicators for colorimetric analysis of enzymes | MILES INC. (US) | 1993-03-02 | — | — | US | disclosed |
| EP-0370492-B1 | INDOLE-ALDEHYDE HAIR DYES | Bristol-Myers Squibb Company (US) | 1993-01-27 | — | — | EP | disclosed |
| US-5122602-A | Optical indicators; medical diagnosis; quantitative analysis; immunoassay | MILES INC. (US) | 1992-06-16 | — | — | US | disclosed |
| US-5108502-A | Azo dyes; water solubility; utility in inks for ink-jet printing | HEWLETT-PACKARD COMPANY (US) | 1992-04-28 | — | — | US | disclosed |
| EP-0368225-B1 | HYDROXYL AMINE DERIVATIVES | BASF Aktiengesellschaft (DE) | 1992-04-15 | — | — | EP | disclosed |
| US-5081301-A | HYDROXYLAMINE DERIVATIVES WHICH ARE INTERMEDIATES FOR MAKING HERBICIDAL COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1992-01-14 | — | — | US | disclosed |
| EP-0383092-A2 | Chromogenic merocyanine enzyme substrates | Bayer Corporation (US) | 1990-08-22 | — | — | EP | disclosed |
| US-4932977-A | Indole-aldehyde hair dyes | CLAIROL INCORPORATED (US) | 1990-06-12 | — | — | US | disclosed |
| EP-0370492-A1 | Indole-aldehyde hair dyes | Bristol-Myers Squibb Company (US) | 1990-05-30 | — | — | EP | disclosed |
| EP-0368225-A1 | Hydroxyl amine derivatives | BASF Aktiengesellschaft (DE) | 1990-05-16 | — | — | EP | disclosed |
| US-4048333-A | Method for treating a picorna virus infection | MEDIZINSKA AKADEMIA (BG) | 1977-09-13 | — | — | US | disclosed |
| US-4048333-A | Method for treating a picorna virus infection | MEDIZINSKA AKADEMIA (BG) | 1977-09-13 | — | — | US | disclosed |
| US-4048333-A | Method for treating a picorna virus infection | MEDIZINSKA AKADEMIA (BG) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130274227-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | MAP3K13, MAP3K3, MAP3K1 | GPR35 2069/4885TDP1 928/4885KMT2A 2811/4885 |
| US-20170079954-A1 | PHARMACEUTICALLY ACCEPTABLE SALTS OF 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | GRK3, DMPK, PRKAG3 | GPR35 910/4885TDP1 1234/4885KMT2A 3524/4885 |
| US-20070254917-A1 | INTRACELLULAR RECEPTOR MODULATOR COMPOUNDS AND METHODS | CASR, GRK2, RYR2 | GPR35 203/4885TDP1 4046/4885KMT2A 4345/4885 |
| US-20150080398-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | MAP3K13, MAP3K3, MAP3K1 | GPR35 2069/4885TDP1 928/4885KMT2A 2811/4885 |
| US-20100261765-A1 | MINERALOCORTICOID RECEPTOR MODULATORS | NR3C2, MC2R, NR3C1 | GPR35 84/4885TDP1 4480/4885KMT2A 3249/4885 |
| US-20150105389-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | MAP3K13, MAP3K3, MAP3K1 | GPR35 2069/4885TDP1 928/4885KMT2A 2811/4885 |
| US-20150080397-A1 | PHARMACEUTICALLY ACCEPTABLE SALTS OF 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | GRK3, DMPK, PRKAG3 | GPR35 910/4885TDP1 1234/4885KMT2A 3524/4885 |
| US-20130303492-A1 | 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | MAP3K13, MAP3K3, MAP3K1 | GPR35 2069/4885TDP1 928/4885KMT2A 2811/4885 |
| US-20040102650-A1 | Solid phase synthesis of arylretinamides | RARA, LRAT, NR2E3 | GPR35 149/4885TDP1 3490/4885KMT2A 527/4885 |
| US-20030105164-A1 | Solid phase synthesis of arylretinamides | RARA, LRAT, NR2E3 | GPR35 149/4885TDP1 3490/4885KMT2A 527/4885 |
| US-20130109029-A1 | Methods And Compositions For Cellular Imaging And Cancer Cell Detection Using Light Harvesting Conjugated Polymer-Biomolecular Conjugates | CA14, EPCAM, CA12 | GPR35 3057/4885TDP1 2910/4885KMT2A 3354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.